3 Best U.S. Stocks Immune To Coronavirus Jitters

 | Mar 27, 2020 08:21AM ET

The novel coronavirus has induced unprecedented volatility in the financial markets since the beginning of this year, prompting both small and large businesses to brood over their ability to keep going once the crisis is over. Investors also hesitated to put their money into stocks, unable to understand which direction the broader markets may trend in the weeks ahead.

However, one must remember in such trying times that the current situation is all but permanent. This temporary weakness induced by the novel coronavirus, like all things bad, shall pass. Keeping this in mind, let us delve deeper and consider a few stocks that are apt for investment despite the gloomy scenario.

Quarantine Measures Are Yielding Results

The deadly disease that originated in Wuhan, China, about three months ago affected more than 549,000 lives globally as of Mar 27. Fears over this highly infectious virus sent several countries on lockdown, hoping that less contact among people may slow the contagion.

This is because although top biotechnology companies, such as Moderna, Inc. (NASDAQ:MRNA) and Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) are working fast toward an experimental vaccine, the results from the initial dosing of Moderna’s antidote will take at least two months to affirm, as Bloomberg Electronics - Semiconductors industry.